Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone

G. Derosa, E. Fogari, A. D'Angelo, A. F G Cicero, S. A T Salvadeo, P. D. Ragonesi, I. Ferrari, A. Gravina, R. Fassi, R. Fogari

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone'. Together they form a unique fingerprint.

Medicine & Life Sciences